Loading...
Entry LevelFull-time
Salary Range
$16,575 - $22,425 /year
This salary is estimated based on similar roles. The actual salary may vary.
About the Role
AbbVie is seeking a Senior FP&A Financial Analyst with expertise in scenario modeling and profitability analysis, particularly within the pharmaceutical industry. The ideal candidate will be responsible for all pricing elements to support the financial planning process, including budgeting, variance analysis, and preparation of adjustments.
Key Responsibilities
- →Review and approve invoices ensuring compliance with product registration agreements
- →Develop and implement robust analytical tools and financial models to support strategic decision-making and scenario planning
- →Manage monthly selling, general, and administrative expenses, including advertising, promotion, and other business unit-related costs
- →Participate actively in the budgeting and financial planning process for pricing elements
- →Collaborate effectively with multiple stakeholders to ensure accurate financial forecasts and reports while fostering a cohesive work environment
- →Provide strategic financial feedback and information to field teams and the Market Access team at headquarters
- →Oversee the review and approval of contracts, ensuring compliance with company policies and objectives
- →Respond to ad-hoc financial requests as needed to contribute to business objectives
Requirements
- ✓Expertise in financial modeling and profitability analysis
- ✓Strong knowledge of the pharmaceutical business
- ✓Experience with pricing strategies and financial planning
- ✓Ability to manage sales, general, and administrative expenses
- ✓Skills in advertising and promotion cost management
- ✓Contract review and compliance experience
- ✓Excellent analytical and problem-solving abilities
- ✓Strong communication and collaboration skills
Free to sign up. Takes 30 seconds.
About Abbvie
Abbvie is a global biopharmaceutical company specializing in the research, development, and commercialization of innovative therapies. Headquartered in North Chicago, Illinois, the company was founded in 2013 following the spin-off of Abbott Laboratories' pharmaceutical division. Abbvie operates at the forefront of the biotechnology and pharmaceutical industries, focusing on addressing complex diseases and improving patient outcomes through scientific advancement. The company's primary products include treatments for immunology, oncology, and neurology, with its flagship drug, Humira, being one of the best-selling medications globally. Abbvie is known for its robust pipeline of investigational therapies, leveraging cutting-edge research and clinical trials to bring novel treatments to market. Its target audience includes patients, healthcare providers, and payers, with a particular emphasis on those suffering from chronic and life-threatening conditions. Key features of Abbvie's offerings include targeted therapies, personalized medicine approaches, and a commitment to regulatory compliance and safety. Abbvie has achieved significant milestones, including maintaining a leading position in the global pharmaceutical market and generating substantial revenue through its innovative portfolio. The company's unique value proposition lies in its dedication to scientific excellence and patient-centric care, supported by a strong pipeline and strategic investments in research and development. Abbvie's market position is further strengthened by its global reach, collaborative partnerships, and a reputation for delivering transformative therapies.
